Prelude Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,758	Closed	-$8K	–	2426
2018 Q4	$8K	Buy	+2,758	New	+$7.58K	﹤0.01%	1442
2017 Q4	–	Sell	-67,233	Closed	-$228K	–	1984
2017 Q3	$228K	Buy	67,233 +39,933	+146%	+$111K	0.02%	605
2017 Q2	$67K	Sell	27,300 -79,800	-75%	-$184K	0.01%	906
2017 Q1	$243K	Buy	107,100 +33,900	+46%	+$75K	0.02%	500
2016 Q4	$155K	Buy	73,200 +34,071	+87%	+$95.1K	0.02%	673
2016 Q3	$131K	Buy	39,129 +9,329	+31%	+$29.6K	0.01%	726
2016 Q2	$94K	Buy	+29,800	New	+$99.4K	0.01%	792
2015 Q4	–	Sell	-34,458	Closed	-$173K	–	1936
2015 Q3	$173K	Buy	+34,458	New	+$197K	0.03%	656
2015 Q2	–	Sell	-4,500	Closed	-$32K	–	2378
2015 Q1	$32K	Hold	4,500	–	–	﹤0.01%	1653
2014 Q4	$35K	Buy	+4,500	New	+$35.6K	0.01%	1550
2014 Q3	–	Sell	-13,800	Closed	-$134K	–	2435
2014 Q2	$134K	Buy	13,800 +7,000	+103%	+$62.4K	0.02%	942
2014 Q1	$57K	Sell	6,800 -2,520	-27%	-$21.6K	0.01%	1263
2013 Q4	$79K	Buy	9,320 +5,120	+122%	+$43.1K	0.01%	954
2013 Q3	$33K	Buy	+4,200	New	+$33.8K	0.01%	1088